COPD medicine delay death puts 3-hour UAE pharmacy approvals under scrutiny

Kenney Blewett, a Texas patient with chronic obstructive pulmonary disease, died by suicide on 7 June 2026 after a prescribed nebulised medicine was delayed over an insurance issue, a case UAE clinics and pharmacies should treat as an approval-triage warning.

The case, reported by CBS News and KFF Health News on 2 October 2026, sits outside UAE law. Its operating lesson is local. In Dubai, the Dubai Health Authority (DHA) regulates health insurance under Law No. 11 of 2013. In Abu Dhabi and Al Ain, the Department of Health Abu Dhabi (DOH Abu Dhabi) sets payer and provider rules. In the northern emirates, Ministry of Health and Prevention (MOHAP) channels apply for private facility issues, while medicine registration and pricing sit with the Emirates Drug Establishment (EDE).

What happened in the CBS case

Blewett saw his pulmonologist on 2 June 2026 for worsening COPD flare-ups. The physician prescribed a liquid medicine for use through a nebuliser. Two days later, Walgreens emailed that the medicine was delayed.

"Due to an insurance issue that we're working to resolve" — Walgreens email quoted by CBS News and KFF Health News.

Blewett's wife, Cindy Blewett, told the reporters that the pharmacy later mentioned prior authorisation. The case then turned on Medicare billing and a possible missing diagnostic code. Walgreens declined to comment on the individual case. The pulmonologist, Rajesh Shetty of LungDocs, did not respond to the reporters.

The UAE has a different payer architecture. The same failure mode can still appear: a high-risk respiratory patient leaves a clinic with a prescription, the pharmacy cannot dispense through direct billing, and no one owns escalation within the first day.

The UAE operating risk

For Dubai operators, the relevant benchmark is the approval workflow written into insurance contracts and DHA-regulated processes. Sukoon, says in its health employee handbook that it aims to respond within 3 hours for outpatient pre-authorisation requests and 6 hours for inpatient requests. Direct-billing providers are responsible for obtaining prior approval where required.

That standard matters for clinics using Daman, Thiqa, Sukoon, NAS, Nextcare or other payer and TPA arrangements. The contract decides the benefit; clinical risk decides escalation. A respiratory flare-up medicine, oncology medicine, anticoagulant, insulin or anti-epileptic should trigger faster handling than a low-risk outpatient claim.

• Clinics should record the payer, TPA, policy number, diagnosis code and urgency at the visit.
• Pharmacies should give the patient and clinic the rejection reason in writing on the same day.
• Insurers and TPAs should track urgent medicine approvals separately from routine outpatient claims.
• CFOs should audit unpaid claims by rejection code, since repeated missing-code denials often signal process failure.

Abu Dhabi has a separate safety backstop. DOH Abu Dhabi has stated that all healthcare facilities in the emirate must receive and treat emergency cases regardless of insurance status or validity, and that patients can contact ISTIJABA on 8001717 for urgent in-patient support. That does not solve routine pharmacy approvals. It defines the line when breathlessness becomes an emergency.

What UAE operators should check now

The practical question is where an approval delay becomes a clinical escalation. DHA's Dubai insurance bylaw requires insurers to observe DHIC timeframes for claim cycles, approval issuance and settlement. DOH Abu Dhabi's claims and adjudication rules apply to approved payers and providers in the Abu Dhabi health insurance scheme. MOHAP's private facility complaint service covers northern-emirate medical and pharmaceutical facilities.

Medicine price checks should use official price files rather than informal pharmacy quotes. EDE's medical products price-list service covers products registered in the UAE. MOHAP has also published a directory service for checking registered medicines, active ingredients, dosage form, package size and selling price. If an operator cannot quote a medicine price with confidence, the correct answer is to check the EDE or MOHAP file by brand name, scientific name or registration details.

For patients, the instruction should be concrete: if a breathing medicine is delayed, call the prescribing clinic the same day, ask the pharmacy for the denial reason in writing, and use the insurer or TPA approval line printed on the insurance card. In Dubai, unresolved insurance complaints can be raised through DHA insurance complaint channels. In Abu Dhabi, DOH Abu Dhabi has a health insurance complaint service.

Clinics should send patients to licensed providers with active insurance connectivity and reachable pharmacists. Readers can check licensed pharmacy providers in the UAE Open Healthcare Directory, which lists 1,680 DHA-licensed pharmacies in Dubai with contact, location and operating details.